A carregar...
Oral itraconazole for epistaxis in hereditary hemorrhagic telangiectasia: a proof of concept study
The inhibiting effects of itraconazole, an antifungal drug on vascular endothelial growth factor (VEGF) have recently been discovered. By inhibiting VEGF, itraconazole has shown potential in clinical trials as anti-cancer treatment. In hereditary hemorrhagic telangiectasia (HHT) patients, VEGF level...
Na minha lista:
| Publicado no: | Angiogenesis |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7615075/ https://ncbi.nlm.nih.gov/pubmed/33211216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10456-020-09758-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|